Crossmark

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

Published Online: 2020-05-31

Published Print: 2020-06

Authors

Saleem, Ramsey

Cantin, Greg

Wikström, Mats

Bolton, Glen

Kuhns, Scott

McBride, Helen J.

Liu, Jennifer
Funding

Funding for this research was provided by:

Amgen
License Information

Text and Data Mining valid from 2020-05-31

Version of Record valid from 2020-05-31
More Information

Article History

Received: 4 December 2019

Accepted: 3 April 2020

First Online: 31 May 2020

Document is current